Dr. Markman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1331 East Wyoming Avenue
Philadelphia, PA 19124Phone+1 215-537-7400
Education & Training
NYU Grossman School of MedicineResidency, Internal Medicine, 1974 - 1978- New York University School of MedicineClass of 1974
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
CA State Medical License 2002 - Present
PA State Medical License 2001 - 2024
GA State Medical License 2012 - 2015
TX State Medical License 2006 - 2012
MI State Medical License 2002 - 2006
OH State Medical License 1992 - 2006
IL State Medical License 2002 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FASCO) American Society of Clinical Oncologists, 2011
Clinical Trials
- S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission Start of enrollment: 1997 Nov 01
- Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum Start of enrollment: 1997 Sep 01
- Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer Start of enrollment: 2001 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 731 citationsPhase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal C...Maurie Markman, Brian N. Bundy, David S. Alberts, Jeffrey M. Fowler, Daniel L. Clark-Pearson
Journal of Clinical Oncology. 2001-02-15 - 648 citationsPrognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group StudyWilliam E. Winter, G. Larry Maxwell, Chunqiao Tian, Jay W. Carlson, Robert F. Ozols
Journal of Clinical Oncology. 2007-08-20 - 19 citationsBRCA1 germline mutations and polymorphisms in a clinic-based series of ovarian cancer cases: a Gynecologic Oncology Group study.Simon A. Smith, William E. Richards, Kathryn Caito, Parviz Hanjani, Maurie Markman
Gynecologic Oncology. 2001-12-01
Other
- Intraperitoneal chemotherapy for treatment of ovarian cancerMarkman M, Walker JL
http://www.uptodate.com/contents/intraperitoneal-chemotherapy-for-treatment-of-ovarian-cancer
UpToDate, Wolters Kluwer Health - 2012-06-14
Press Mentions
Only 7% of Patients with Cancer Participate in Clinical Trials: Far from AdequateNovember 13th, 2024- From Clinical Trials to Clinical Practice: COX-2 InhibitionOctober 28th, 2024
- Study Reveals Challenges in Health Literacy of PatientsOctober 23rd, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
